+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computed Tomography (CT) Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5780633
The global computed tomography market size reached a value of USD 6.22 billion in 2022. The market is likely to grow at a rate of 6.0% during the forecast period of 2023-2031 to attain a market value of USD 10.44 billion by 2031, driven by the rising demand for diagnostics.

Computed Tomography (CT) Market: Introduction

Computed tomography (CT) is a medical imaging technique that uses X-ray equipment and computers to produce detailed cross-sectional images of the body. It is a non-invasive diagnostic imaging tool that is used to examine internal structures, identify abnormalities, and guide therapeutic interventions. The global CT market is driven by factors such as increasing prevalence of chronic diseases, technological advancements in imaging modalities and rising demand for minimally invasive diagnostic procedures.

Computed Tomography (CT) Market- Application and Usage

Computed Tomography (CT) is a medical imaging technology that uses X-rays and computer algorithms to produce detailed images of the body. CT imaging is widely used in medical practice and has a variety of applications and uses, including:
1. Diagnosis of Medical Conditions: CT imaging is commonly used to diagnose medical conditions such as cancers, cardiovascular diseases, and neurological disorders. It can provide detailed images of the affected area, allowing doctors to detect and diagnose these conditions at an early stage.
2. Planning for Surgery: CT imaging is used to plan for surgical procedures, particularly in complex surgeries where detailed information about the affected area is crucial. CT scans can provide a detailed map of the body, enabling surgeons to plan their approach and identify any potential complications.
3. Monitoring of Medical Conditions: CT imaging is often used to monitor the progression of medical conditions such as cancers and other diseases. Regular CT scans can help doctors track the development of a condition and assess the effectiveness of treatment.
4. Evaluation of Trauma: CT imaging is used to evaluate patients who have suffered from trauma, such as accidents or injuries. CT scans can quickly provide a detailed assessment of the extent of the injury, allowing doctors to make informed decisions about the appropriate course of treatment.
5. Diagnosis of Dental and Oral Conditions: CT imaging is used to diagnose dental and oral conditions such as temporomandibular joint disorder (TMJ) and impacted wisdom teeth. CT scans can provide detailed images of the teeth, jaw, and surrounding tissues, allowing dentists to diagnose and treat these conditions accurately.
6. Detection of Abnormalities: CT imaging is used to detect abnormalities such as tumors, cysts, and other growths. CT scans can provide detailed images of the affected area, allowing doctors to identify abnormalities and determine the appropriate course of treatment.

Overall, CT imaging is a versatile and widely used medical imaging technology with a variety of applications and uses. Its ability to provide detailed and accurate images of the body makes it an essential tool for the diagnosis and treatment of many medical conditions.

Computed Tomography (CT) Market Segmentations

The market can be categorised into technology, application, modality, end user, and region.

Market Breakup by Technology

  • High Slice
  • Mid Slice
  • Low Slice
  • Cone Beam Computed Tomography (CBCT)

Market Breakup by Application

  • Orthopaedics
  • Cardiovascular
  • Oncology
  • Neurology
  • Others

Market Breakup by Modality

  • O-Arm
  • C-Arm

Market Breakup by End User

  • Hospitals and ICUs
  • Ambulatory Surgical and Diagnostic Centres
  • Nursing Homes and Maternity Centres

Computed Tomography (CT) Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Computed Tomography (CT) Market Scenario

The global CT market is expected to grow significantly in the coming years. The market is being driven by factors such as the increasing prevalence of chronic diseases, technological advancements in CT imaging, and the rising geriatric population. The high-end slice CT segment is expected to dominate the market due to its ability to provide high-quality images and a higher level of accuracy. The oncology application is expected to have the largest market share due to the increasing incidence of cancer globally.

Geographically, North America dominates the CT market due to the presence of key players, favourable reimbursement policies, and a high prevalence of chronic diseases. The Asia-Pacific region is expected to witness the highest growth rate due to the increasing healthcare expenditure, rising awareness about early disease diagnosis, and the presence of a large patient pool. Furthermore, the increasing demand for CT imaging in emerging economies such as China and India is expected to drive the growth of the CT market in the Asia-Pacific region.

Key Players in the Global Computed Tomography (CT) Market

The report gives an in-depth analysis of the key players involved in the computed tomography (CT) market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • General Electric Company
  • Hitachi, Ltd
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V
  • Neusoft Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Planmca Oy
  • Fujifilm Corporation
  • NeuroLogica Corp

Table of Contents

1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology3 Executive Summary
4 Global Computed Tomography Market
4.1 Global Computed Tomography Market Overview
4.2 Global Computed Tomography Market Analysis
4.2.1 Market Overview
4.2.1.1 Global Computed Tomography Market Historical Value (2016-2022)
4.2.1.2 Global Computed Tomography Market Forecast Value (2023-2031)
4.3 Global Computed Tomography Market by Technology
4.3.1 Market Overview
4.3.1.1 High Slice
4.3.1.2 Mid Slice
4.3.1.3 Low Slice
4.3.1.4 Cone Beam Computed Tomography (CBCT)
4.4 Global Computed Tomography Market by Application
4.4.1 Market Overview
4.4.1.1 Orthopaedics
4.4.1.2 Cardiovascular
4.4.1.3 Oncology
4.4.1.4 Neurology
4.4.1.5 Others
4.5 Global Computed Tomography Market by Modality
4.5.1 Market Overview
4.5.1.1 O Arm
4.5.1.2 C Arm
4.6 Global Computed Tomography Market by End User
4.6.1 Market Overview
4.6.1.1 Hospitals and ICUs
4.6.1.2 Ambulatory Surgical and Diagnostic Centres
4.6.1.3 Nursing Homes and Maternity Centres
4.7 Global Computed Tomography Market by Region
4.7.1 Market Overview
4.7.1.1 North America
4.7.1.1.1 Historical Trend (2016-2022)
4.7.1.1.2 Forecast Trend (2023-2031)
4.7.1.2 Europe
4.7.1.2.1 Historical Trend (2016-2022)
4.7.1.2.2 Forecast Trend (2023-2031)
4.7.1.3 Asia Pacific
4.7.1.3.1 Historical Trend (2016-2022)
4.7.1.3.2 Forecast Trend (2023-2031)
4.7.1.4 Latin America
4.7.1.4.1 Historical Trend (2016-2022)
4.7.1.4.2 Forecast Trend (2023-2031)
4.7.1.5 Middle East and Africa
4.7.1.5.1 Historical Trend (2016-2022)
4.7.1.5.2 Forecast Trend (2023-2031)
5 North America Computed Tomography Market
5.1 United States of America
5.1.1 Historical Trend (2016-2022)
5.1.2 Forecast Trend (2023-2031)
5.2 Canada
5.2.1 Historical Trend (2016-2022)
5.2.2 Forecast Trend (2023-2031)
6 Europe Computed Tomography Market
6.1 United Kingdom
6.1.1 Historical Trend (2016-2022)
6.1.2 Forecast Trend (2023-2031)
6.2 Germany
6.2.1 Historical Trend (2016-2022)
6.2.2 Forecast Trend (2023-2031)
6.3 France
6.3.1 Historical Trend (2016-2022)
6.3.2 Forecast Trend (2023-2031)
6.4 Italy
6.4.1 Historical Trend (2016-2022)
6.4.2 Forecast Trend (2023-2031)
7 Asia Pacific Computed Tomography Market
7.1 China
7.1.1 Historical Trend (2016-2022)
7.1.2 Forecast Trend (2023-2031)
7.2 Japan
7.2.1 Historical Trend (2016-2022)
7.2.2 Forecast Trend (2023-2031)
7.3 India
7.3.1 Historical Trend (2016-2022)
7.3.2 Forecast Trend (2023-2031)
7.4 ASEAN
7.4.1 Historical Trend (2016-2022)
7.4.2 Forecast Trend (2023-2031)
7.5 Australia
7.5.1 Historical Trend (2016-2022)
7.5.2 Forecast Trend (2023-2031)
8 Latin America Computed Tomography Market
8.1 Brazil
8.1.1 Historical Trend (2016-2022)
8.1.2 Forecast Trend (2023-2031)
8.2 Argentina
8.2.1 Historical Trend (2016-2022)
8.2.2 Forecast Trend (2023-2031)
8.3 Mexico
8.3.1 Historical Trend (2016-2022)
8.3.2 Forecast Trend (2023-2031)
9 Middle East and Africa Computed Tomography Market
9.1 Saudi Arabia
9.1.1 Historical Trend (2016-2022)
9.1.2 Forecast Trend (2023-2031)
9.2 United Arab Emirates
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Nigeria
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
9.4 South Africa
9.4.1 Historical Trend (2016-2022)
9.4.2 Forecast Trend (2023-2031)
10 Trade Data Analysis by HS Code
10.1 Computed Tomography Apparatus- 90221200
10.2 Computed Tomography Scanners- 902212
11 Current Scenario Evaluation and Regulatory Framework
11.1 Emerging Therapies and Clinical Trials Synopsis
11.2 Patent Landscape
11.2.1 Patent Overview
11.2.1.1 Patent Status and Expiry
11.2.1.2 Timelines from Device Development to Commercial Launch
11.2.1.3 New Device Application
11.2.1.3.1 Documentation and Approval Process
11.3 Cost of Treatment
11.4 Regulatory Framework
11.4.1 Regulatory Overview
11.4.1.1 US FDA
11.4.1.2 EU EMA
11.4.1.3 INDIA CDSCO
11.4.1.4 JAPAN PMDA
11.4.1.5 Others
12 Global Computed Tomography Market Dynamics
12.1 Market Drivers and Constraints
12.2 SWOT Analysis
12.3 Porter’s Five Forces Model
12.4 Key Demand Indicators
12.5 Key Price Indicators
12.6 Industry Events, Initiatives, and Trends
12.7 Value Chain Analysis
13 Supplier Landscape
13.1 General Electric Company
13.1.1 Company Overview
13.1.2 Product Portfolio
13.1.3 Demographic Reach and Achievements
13.1.4 Mergers and Acquisitions
13.1.5 Certifications
13.2 Hitachi, Ltd.
13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Siemens Healthcare GmbH
13.3.1 Company Overview
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Koninklijke Philips N.V.
13.4.1 Company Overview
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Neusoft Corporation
13.5.1 Company Overview
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Canon Medical Systems Corporation
13.6.1 Company Overview
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Carestream Health
13.7.1 Company Overview
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Planmca Oy
13.8.1 Company Overview
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Fujifilm Corporation
13.9.1 Company Overview
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 NeuroLogica Corp.
13.10.1 Company Overview
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 Recommendations and Discussion
15 Pricing Models and Strategies (Additional Insight)
15.1 Overview
15.2 Cost Model
15.2.1 Manufacturing Cost Analysis
15.2.2 Procurement Cost Analysis
15.2.3 Clinical Trial Cost Factors
15.3 Pricing Strategies
15.3.1 Competitor Pricing Analysis
15.3.2 Key Assessment of Product Attributes
15.3.3 Pricing Benchmark
16 Global Computed Tomography Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment

Companies Mentioned

  • General Electric Company
  • Hitachi, Ltd.
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V.
  • Neusoft Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Planmca Oy
  • Fujifilm Corporation
  • NeuroLogica Corp.

Methodology

Loading
LOADING...

Table Information